Insider holders · CIK 0001641640
Nabriva Therapeutics plc · NBRV
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| HBM Healthcare Investments (Cayman) Ltd.10% Owner | 2,334,128 | — | 2,334,128 | Sep 14, 2017 · 8:21 pm EDT | Form 4 |
| Vivo Capital VIII, LLC10% Owner | — | 494,329 | 494,329 | Sep 18, 2017 · 9:13 pm EDT | Form 4 |
| OrbiMed Capital GP V LLCDirector | — | 224,166 | 224,166 | Dec 30, 2016 · 4:21 pm EST | Form 3 |
| Chau Quang KhuongDirector | — | 224,166 | 224,166 | Dec 30, 2016 · 4:20 pm EST | Form 3 |
| ORBIMED ADVISORS LLCDirector | — | 224,166 | 224,166 | Dec 30, 2016 · 4:21 pm EST | Form 3 |
| Samuel D IsalyDirector | — | 224,166 | 224,166 | Dec 30, 2016 · 4:21 pm EST | Form 3 |
| Colin Broom M.D.CEO & Director | 102,151 | 72,849 | 175,000 | Jun 25, 2018 · 9:47 am EDT | Form 4 |
| Theodore R SchroederChief Executive Officer | — | 60,741 | 60,741 | Jul 27, 2018 · 5:29 pm EDT | Form 3 |
| Charles A Rowland Jr.Director | 53,000 | — | 53,000 | Dec 27, 2018 · 4:05 pm EST | Form 4 |
| George Harrison TalbotDirector | 47,640 | — | 47,640 | Aug 2, 2018 · 5:52 pm EDT | Form 4 |
| Daniel D BurgessDirector | 36,000 | — | 36,000 | Aug 2, 2018 · 5:51 pm EDT | Form 4 |
| Steven P. GeloneChief Scientific Officer | 22,740 | — | 22,740 | Jun 26, 2018 · 9:09 am EDT | Form 4 |
| Robert CrottyGeneral Counsel & Secretary | 10,000 | — | 10,000 | May 23, 2018 · 12:29 pm EDT | Form 4 |
| Stephen W WebsterDirector | 8,000 | — | 8,000 | May 23, 2018 · 8:37 pm EDT | Form 4 |
| Gary SenderChief Financial Officer | 6,200 | — | 6,200 | May 23, 2018 · 8:38 pm EDT | Form 4 |
| Jennifer SchranzChief Medical Officer | 5,500 | — | 5,500 | Jun 25, 2018 · 9:47 am EDT | Form 4 |
| Francesco Maria LavinoChief Commercial Officer | 3,719 | — | 3,719 | May 29, 2018 · 1:48 pm EDT | Form 4 |
| John Peter Wolf IIIGeneral Counsel and Corp. Sec. | 270 | — | 270 | Dec 30, 2016 · 4:25 pm EST | Form 3 |
| Elyse G. SeltzerChief Medical Officer | 240 | — | 240 | Dec 30, 2016 · 4:24 pm EST | Form 3 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.